Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2011 (2011), Article ID 438184, 7 pages
http://dx.doi.org/10.4061/2011/438184
Review Article

Hepatobiliary Disorders in Celiac Disease: An Update

1Department of Superspeciality of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India
2Division of GE Histopathology, Department of Superspeciality of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India
3Department of Radiodiagnosis, Government Medical College & Hospital, Sector 32, Chandigarh 160030, India

Received 6 July 2010; Revised 2 September 2010; Accepted 6 October 2010

Academic Editor: Takuji Torimura

Copyright © 2011 Kaushal K. Prasad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Trier, “Medical progress: celiac sprue,” New England Journal of Medicine, vol. 325, no. 24, pp. 1709–1719, 1991. View at Google Scholar · View at Scopus
  2. K. K. Prasad, B. R. Thapa, C. K. Nain, A. K. Sharma, and K. Singh, “Brush border enzyme activities in relation to histological lesion in pediatric celiac disease,” Journal of Gastroenterology and Hepatology, vol. 23, no. 8, pp. e348–e352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. K. Prasad, B. R. Thapa, C. K. Nain, and K. Singh, “Assessment of the diagnostic value of duodenal bulb histology in patients with celiac disease, using multiple biopsy sites,” Journal of Clinical Gastroenterology, vol. 43, no. 4, pp. 307–311, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. K. Prasad, B. R. Thapa, C. K. Nain, and K. Singh, “Assessment of histologic lesion variability of the duodenal mucosa in children with celiac disease,” World Journal of Pediatrics, vol. 6, pp. 60–64, 2010. View at Google Scholar
  5. M. N. Marsh, “Grains of truth: evolutionary changes in small intestinal mucosa in response to environmental antigen challenge,” Gut, vol. 31, no. 1, pp. 111–114, 1990. View at Google Scholar · View at Scopus
  6. S. Soto Iglesias, S. Vázquez Rodríguez, J. L. Ulla Rocha et al., “Onset of celiac disease after acute hepatitis B infection,” Gastroenterologia y Hepatologia, vol. 33, no. 1, pp. 17–20, 2010. View at Publisher · View at Google Scholar
  7. L. Plot and H. Amital, “Infectious associations of Celiac disease,” Autoimmunity Reviews, vol. 8, no. 4, pp. 316–319, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Aguancha, J. M. Valera, C. Hurtado, G. Smok, and J. Brahm, “Chronic hepatitis C and celiac sprue: an infrequent association,” Gastroenterologia y Hepatologia, vol. 27, no. 7, pp. 408–410, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. L. C. Stene, M. C. Honeyman, E. J. Hoffenberg et al., “Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study,” American Journal of Gastroenterology, vol. 101, no. 10, pp. 2333–2340, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Lawler, P. Humphries, C. O'Farrelly et al., “Adenovirus 12 E1A gene detection by polymerase chain reaction in both the normal and coeliac duodenum,” Gut, vol. 35, no. 9, pp. 1226–1232, 1994. View at Google Scholar · View at Scopus
  11. S. L. Smits, M. Van Leeuwen, A. A. Van Der Eijk et al., “Human astrovirus infection in a patient with new-onset celiac disease,” Journal of Clinical Microbiology, vol. 48, no. 9, pp. 3416–3418, 2010. View at Publisher · View at Google Scholar
  12. L. Plot, H. Amital, O. Barzilai, M. Ram, B. Nicola, and Y. Shoenfeld, “Infections may have a protective role in the etiopathogenesis of celiac disease,” Annals of the New York Academy of Sciences, vol. 1173, pp. 670–674, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Lal, C. K. Nain, K. K. Prasad, and B. R. Thapa, “Celiac disease in Chandigarh: a population survey,” Indian Journal of Gastroenterology, vol. 24, supplement 1, p. A39, 2005. View at Google Scholar
  14. G. R. Corazza, M. Frisoni, E. A. Treggiari et al., “Subclinical celiac sprue: increasing occurrence and clues to its diagnosis,” Journal of Clinical Gastroenterology, vol. 16, no. 1, pp. 16–21, 1993. View at Google Scholar · View at Scopus
  15. T. P. Chorzelski, E. H. Beutner, and J. Sulej, “IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease,” British Journal of Dermatology, vol. 111, no. 4, pp. 395–402, 1984. View at Google Scholar
  16. D. Schuppan and E. G. Hahn, “IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening,” European Journal of Gastroenterology and Hepatology, vol. 13, no. 6, pp. 635–637, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Pacht, N. Sinai, L. Hornstein, V. Kumar, N. Ish-Shalom, and A. Lerner, “The diagnostic reliability of anti-endomysial antibody in celiac disease: the north Israel experience,” Israel Journal of Medical Sciences, vol. 31, no. 4, pp. 218–220, 1995. View at Google Scholar · View at Scopus
  18. S. Niveloni, E. Sugai, A. Cabanne et al., “Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease,” Clinical Chemistry, vol. 53, no. 12, pp. 2186–2192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Sugai, M. L. Moreno, H. J. Hwang et al., “Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable?” World Journal of Gastroenterology, vol. 16, no. 25, pp. 3144–3152, 2010. View at Publisher · View at Google Scholar
  20. P. Collin, K. Kaukinen, M. Välimäki, and J. Salmi, “Endocrinological disorders and celiac disease,” Endocrine Reviews, vol. 23, no. 4, pp. 464–483, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Ferrante, C. Giavoli, L. Elli et al., “Evaluation of GH-IGF-I axis in adult patients with coeliac disease,” Hormone and Metabolic Research, vol. 42, no. 1, pp. 45–49, 2010. View at Publisher · View at Google Scholar
  22. M. Delvecchio, A. De Bellis, R. Francavilla et al., “Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment,” American Journal of Gastroenterology, vol. 105, no. 3, pp. 691–696, 2010. View at Publisher · View at Google Scholar
  23. K. D. Jhaveri, V. D. D'Agati, R. Pursell, and D. Serur, “Coeliac sprue-associated membranoproliferative glomerulonephritis (MPGN),” Nephrology Dialysis Transplantation, vol. 24, no. 11, pp. 3545–3548, 2009. View at Publisher · View at Google Scholar
  24. H. K. Smerud, B. Fellström, R. Hällgren, S. Osagie, P. Venge, and G. Kristjánsson, “Gluten sensitivity in patients with IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 24, no. 8, pp. 2476–2481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Zingone, C. Bucci, R. Tortora et al., “Body mass index and prevalence of skin diseases in adults with untreated coeliac disease,” Digestion, vol. 80, no. 1, pp. 18–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. H. J. Freeman, “Neurological disorders in adult celiac disease,” Canadian Journal of Gastroenterology, vol. 22, no. 11, pp. 909–911, 2008. View at Google Scholar · View at Scopus
  27. K. K. Prasad, S. Siwatch, S. K. Sinha, C. K. Nain, and K. Singh, “Celiac disease and reproductive disorders: association is often neglected,” Gastroenterology Today, vol. 11, pp. 50–54, 2007. View at Google Scholar
  28. H. J. Freeman, “Hepatobiliary and pancreatic disorders in celiac disease,” World Journal of Gastroenterology, vol. 12, no. 10, pp. 1503–1508, 2006. View at Google Scholar · View at Scopus
  29. J. E. Naschitz, D. Yeshurun, E. Zuckerman, E. Arad, and J. H. Boss, “Massive hepatic steatosis complicating adult celiac disease: report of a case and review of the literature,” American Journal of Gastroenterology, vol. 82, no. 11, pp. 1186–1189, 1987. View at Google Scholar · View at Scopus
  30. D. J. Pollock, “The liver in coeliac disease,” Histopathology, vol. 1, no. 6, pp. 421–430, 1977. View at Google Scholar · View at Scopus
  31. T. H. Casswall, N. Papadogiannakis, S. Ghazi, and A. Németh, “Severe liver damage associated with celiac disease: findings in six toddler-aged girls,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 4, pp. 452–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. D. Cantarero Vallejo, J. Gómez Camarero, L. Menchén, J. A. Pajares Díaz, and O. Lo Iacono, “Liver damage and celiac disease,” Revista Espanola de Enfermedades Digestivas, vol. 99, no. 11, pp. 648–652, 2007. View at Google Scholar · View at Scopus
  33. P. M. Lepper and J.-F. Dufour, “Elevated transaminases—what to do if everything was done?” Praxis, vol. 98, no. 6, pp. 330–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. B. Villares, J. A. M. Monteagudo, R. M. Borque, and R. M. Otero, “Hepatic involvement in celiac disease,” Gastroenterologia y Hepatologia, vol. 31, no. 1, pp. 25–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. U. Volta, “Pathogenesis and clinical significance of liver injury in celiac disease,” Clinical Reviews in Allergy and Immunology, vol. 36, no. 1, pp. 62–70, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Rubio-Tapia and J. A. Murray, “The liver in celiac disease,” Hepatology, vol. 46, no. 5, pp. 1650–1658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Maggiore and S. Caprai, “Liver involvement in celiac disease,” Indian Journal of Pediatrics, vol. 73, no. 9, pp. 809–811, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Bayard, J. Holt, and E. Boroughs, “Nonalcoholic fatty liver disease,” American Family Physician, vol. 73, no. 11, pp. 1961–1969, 2006. View at Google Scholar · View at Scopus
  39. J. M. Valera, C. Hurtado, J. Poniachik, P. Abumohor, and J. Brahm, “Study of celiac disease in patients with non-alcoholic fatty liver and autoimmune hepatic diseases,” Gastroenterologia y Hepatologia, vol. 31, no. 1, pp. 8–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. T. Bardella, L. Valenti, C. Pagliari et al., “Searching for coeliac disease in patients with non-alcoholic fatty liver disease,” Digestive and Liver Disease, vol. 36, no. 5, pp. 333–336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Franzese, M. P. Iannucci, G. Valerio et al., “Atypical celiac disease presenting as obesity-related liver dysfunction,” Journal of Pediatric Gastroenterology and Nutrition, vol. 33, no. 3, pp. 329–332, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Miele, V. Valenza, G. La Torre et al., “Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease,” Hepatology, vol. 49, no. 6, pp. 1877–1887, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Caprai, P. Vajro, A. Ventura, M. Sciveres, and G. Maggiore, “Autoimmune liver disease associated with celiac disease in childhood: a multicenter study,” Clinical Gastroenterology and Hepatology, vol. 6, no. 7, pp. 803–806, 2008. View at Publisher · View at Google Scholar
  44. A. Rubio-Tapia, A. S. Abdulkarim, R. H. Wiesner, S. B. Moore, P. K. Krause, and J. A. Murray, “Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation,” Liver International, vol. 28, no. 4, pp. 467–476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Mirzaagha, S. H. Azali, F. Islami et al., “Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review,” Digestive and Liver Disease, vol. 42, no. 9, pp. 620–623, 2010. View at Publisher · View at Google Scholar
  46. J. F. Ludvigsson, P. Elfström, U. BroomÉ, A. Ekbom, and S. M. Montgomery, “Celiac disease and risk of liver disease: a general population-based study,” Clinical Gastroenterology and Hepatology, vol. 5, no. 1, pp. 63–69.e1, 2007. View at Publisher · View at Google Scholar
  47. D. Villalta, D. Girolami, E. Bidoli et al., “High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies,” Journal of Clinical Laboratory Analysis, vol. 19, no. 1, pp. 6–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. U. Volta, L. De Franceschi, N. Molinaro et al., “Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis,” Digestive Diseases and Sciences, vol. 43, no. 10, pp. 2190–2195, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. M. A. Quail, R. K. Russell, C. Bellamy, G. Mieli-Vergani, and P. M. Gillett, “Seronegative autoimmune hepatitis presenting after diagnosis of coeliac disease: a case report,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 5, pp. 576–579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. R. Di Biase, A. Colecchia, E. Scaioli et al., “Autoimmune liver diseases in a paediatric population with coeliac disease—a 10-year single-centre experience,” Alimentary Pharmacology and Therapeutics, vol. 31, no. 2, pp. 253–260, 2010. View at Publisher · View at Google Scholar
  51. R. E. Sedlack, T. C. Smyrk, A. J. Czaja, and J. A. Talwalkar, “Celiac disease-associated autoimmune cholangitis,” American Journal of Gastroenterology, vol. 97, no. 12, pp. 3196–3198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. J. E. Hay, R. H. Wiesner, R. G. Shorter, N. F. LaRusso, and W. P. Baldus, “Primary sclerosing cholangitis and celiac disease. A novel association,” Annals of Internal Medicine, vol. 109, no. 9, pp. 713–717, 1988. View at Google Scholar · View at Scopus
  53. U. Volta, L. Rodrigo, A. Granito et al., “Celiac disease in autoimmune cholestatic liver disorders,” American Journal of Gastroenterology, vol. 97, no. 10, pp. 2609–2613, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. I. Venturini, R. Cosenza, L. Miglioli et al., “Adult celiac disease and primary sclerosing cholangitis: two case reports,” Hepato-Gastroenterology, vol. 45, no. 24, pp. 2344–2347, 1998. View at Google Scholar · View at Scopus
  55. R. F. A. Logan, A. Ferguson, N. D. C. Finlayson, and D. G. Weir, “Primary biliary cirrhosis and coeliac disease. An association?” Lancet, vol. 1, no. 8058, pp. 230–233, 1978. View at Google Scholar · View at Scopus
  56. W. Dickey, S. A. McMillan, and M. E. Callender, “High prevalence of celiac spree among patients with primary biliary cirrhosis,” Journal of Clinical Gastroenterology, vol. 25, no. 1, pp. 328–329, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Floreani, C. Betterle, A. Baragiotta et al., “Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy,” Digestive and Liver Disease, vol. 34, no. 4, pp. 258–261, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Whittington, “The C282Y mutation may have been positively selected as it mitigates the infertility of celiac disease,” Medical Hypotheses, vol. 66, no. 4, pp. 769–772, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Bevan, S. Popat, C. P. Braegger et al., “Contribution of the MHC region to the familial risk of coeliac disease,” Journal of Medical Genetics, vol. 36, no. 9, pp. 687–690, 1999. View at Google Scholar · View at Scopus
  60. C. Q. Edwards, M. M. Dadone, M. H. Skolnick, and J. P. Kushner, “Hereditary hemochromatosis,” Clinical Hematology, vol. 11, pp. 411–435, 1982. View at Google Scholar
  61. J. R. Butterworth, B. T. Cooper, W. M. C. Rosenberg et al., “The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease,” Gastroenterology, vol. 123, no. 2, pp. 444–449, 2002. View at Publisher · View at Google Scholar
  62. A. Geier, C. Gartung, I. Theurl et al., “Occult celiac disease prevents penetrance of hemochromatosis,” World Journal of Gastroenterology, vol. 11, no. 21, pp. 3323–3326, 2005. View at Google Scholar · View at Scopus
  63. D. Barisani, S. Ceroni, S. Del Bianco, R. Meneveri, and M. T. Bardella, “Hemochromatosis gene mutations and iron metabolism in celiac disease,” Haematologica, vol. 89, no. 11, pp. 1299–1305, 2004. View at Google Scholar · View at Scopus
  64. M. Fraquelli, M. Pagliarulo, A. Colucci, S. Paggi, and D. Conte, “Gallbladder motility in obesity, diabetes mellitus and coeliac disease,” Digestive and Liver Disease, vol. 35, no. 3, pp. S12–S16, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Freeman, M. Lemoyne, and P. Pare, “Coeliac disease,” Best Practice and Research in Clinical Gastroenterology, vol. 16, no. 1, pp. 37–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Ben Hriz, H. Habbassi, N. Maamouri et al., “Budd-Chiari syndrome associated with celiac disease,” Revue de Medecine Interne, vol. 31, no. 2, pp. 160–162, 2010. View at Publisher · View at Google Scholar
  67. R. Kochhar, I. Masoodi, U. Dutta et al., “Celiac disease and Budd Chiari syndrome: report of a case with review of literature,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 9, pp. 1092–1094, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. F. Martínez, M. Berenguer, M. Prieto, H. Montes, M. Rayón, and J. Berenguer, “Budd-Chiari syndrome caused by membranous obstruction of the inferior vena cava associated with coeliac disease,” Digestive and Liver Disease, vol. 36, no. 2, pp. 157–162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Gelsi, F. Ruitord, M.-C. Saint-Paul, J. Filippi, K. Arab, and X. Hébuterne, “Association of Budd-Chiari syndrome with a coeliac disease in patient native from North Africa,” Gastroenterologie Clinique et Biologique, vol. 28, no. 10, pp. 903–905, 2004. View at Google Scholar · View at Scopus
  70. E. Biecker, J. Trebicka, H.-P. Fischer, T. Sauerbruch, and F. Lammert, “Portal hypertension and nodular regenerative hyperplasia in a patient with celiac disease,” Zeitschrift fur Gastroenterologie, vol. 44, no. 5, pp. 395–398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Tinsa, I. Brini, A. El May, D. Bousnina, K. Boussetta, and S. Bousnina, “Nodular regenerative hyperplasia of the liver, coeliac disease and Sjogren's syndrome in a child,” Gastroenterologie Clinique et Biologique, vol. 34, no. 1, pp. 40–42, 2010. View at Publisher · View at Google Scholar
  72. E. L. R. Cancado, D. M. Medeiros, M. M. Deguti et al., “Celiac disease associated with nodular regenerative hyperplasia, pulmonary abnormalities, and IgA anticardiolipin antibodies,” Journal of Clinical Gastroenterology, vol. 40, no. 2, pp. 135–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Austin, E. Campbell, P. Lane, and E. Elias, “Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody,” Gut, vol. 53, no. 7, pp. 1032–1034, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Okudaira, M. Ohbu, and K. Okuda, “Idiopathic portal hypertension and its pathology,” Seminars in Liver Disease, vol. 22, no. 1, pp. 59–71, 2002. View at Google Scholar · View at Scopus
  75. K. K. Prasad, “Histopathological changes in liver diseases,” in Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases, M. A. Mahtab and S. Rahman, Eds., pp. 69–106, Elsevier, Chennai, India, 2009. View at Google Scholar
  76. R. K. Dhiman, Y. Chawla, R. K. Vasishta et al., “Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature,” Journal of Gastroenterology and Hepatology, vol. 17, no. 1, pp. 6–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. B. C. Sharma, D. K. Bhasin, and R. Nada, “Association of celiac disease with non-cirrhotic portal fibrosis,” Journal of Gastroenterology and Hepatology, vol. 21, no. 1, pp. 332–334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Zamani, A. Amiri, R. Shakeri, A. Zare, and M. Mohamadnejad, “Celiac disease as a potential cause of idiopathic portal hypertension: a case report,” Journal of Medical Case Reports, vol. 3, article no. 68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Kara and M. Sandikci, “Successful treatment of portal hypertension and hypoparathyroidism with a gluten-free diet,” Journal of Clinical Gastroenterology, vol. 41, no. 7, pp. 724–725, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. C. Catassi, I. Bearzi, and G. K. T. Holmes, “Association of celiac disease and intestinal lymphomas and other cancers,” Gastroenterology, vol. 128, no. 4, pp. S79–S86, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. N. L. Harris, E. S. Jaffe, H. Stein et al., “A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group,” Blood, vol. 84, no. 5, pp. 1361–1392, 1994. View at Google Scholar · View at Scopus
  82. J.-P. Farcet, P. Gaulard, J.-P. Marolleau et al., “Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor γδ,” Blood, vol. 75, no. 11, pp. 2213–2219, 1990. View at Google Scholar · View at Scopus
  83. F. M. Stevens and R. M. McLoughlin, “Is coeliac disease a potentially treatable cause of liver failure?” European Journal of Gastroenterology and Hepatology, vol. 17, no. 10, pp. 1015–1017, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Kaukinen, L. Halme, P. Collin et al., “Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure,” Gastroenterology, vol. 122, no. 4, pp. 881–888, 2002. View at Google Scholar · View at Scopus
  85. D. Villalta, M. Crovatto, S. Stella, E. Tonutti, R. Tozzoli, and N. Bizzaro, “False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent,” Clinica Chimica Acta, vol. 356, no. 1-2, pp. 102–109, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Sárdy, M. Csikós, C. Geisen et al., “Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive disease,” Clinica Chimica Acta, vol. 376, no. 1-2, pp. 126–135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. N. Bizzaro, M. Tampoia, D. Villalta et al., “Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis,” Journal of Clinical Laboratory Analysis, vol. 20, no. 5, pp. 184–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. L. M. Luft, S. G. Barr, L. O. Martin, E. K. L. Chan, and M. J. Fritzler, “Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases,” Journal of Rheumatology, vol. 30, no. 12, pp. 2613–2619, 2003. View at Google Scholar · View at Scopus